• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

CRISPR/Cas9 介导的 FOXP3-TSDR 去甲基化促进 Jurkat T 细胞向 Treg 特征性编程。

CRISPR/Cas9-mediated demethylation of FOXP3-TSDR toward Treg-characteristic programming of Jurkat T cells.

机构信息

Institute of Medical Microbiology, University Hospital Essen, University of Duisburg-Essen, Germany.

Institute of Human Genetics, University Hospital Essen, University of Duisburg-Essen, Germany; Leibniz Institute DSMZ - German Collection of Microorganisms and Cell Cultures GmbH, Braunschweig, Germany.

出版信息

Cell Immunol. 2022 Jan;371:104471. doi: 10.1016/j.cellimm.2021.104471. Epub 2021 Dec 20.

DOI:10.1016/j.cellimm.2021.104471
PMID:34954490
Abstract

Demethylation of FOXP3-TSDR (Treg specific demethylated region) is a hallmark of stable differentiation and suppressive function of regulatory T (Treg) cells. Previous protocols aiming at human naïve T cell differentiation failed to implement a Treg cell specific epigenetic signature. Ten-eleven translocation (TET) enzymes catalyze DNA demethylation. Plasmids towardexpression of a fusion protein encompassing nonfunctional Cas9, the catalytic domain of TET1, blue fluorescent protein, and encoding single guide RNAs (sgRNAs) targeting specific segments of the FOXP3-TSDR were engineered and transfected into Jurkat T cells. FOXP3-TSDR methylation was analyzed by deep-amplicon bisulfite sequencing while cellular Foxp3, Tbet, Gata3, and Rorgt mRNA levels were determined by real-time PCR. Overexpression of dCas9TET1 significantly decreased Jurkat cell FOXP3-TSDR methylation and increased Foxp3 mRNA expression while expressions of master transcription factor mRNAs of other major T cell lineages remained largely unaffected. dCas9-TET1 construct transfection mediated Treg programming of patients' primary T cells might be feasible.

摘要

FOXP3-TSDR(调节性 T 细胞特异性去甲基化区域)的去甲基化是调节性 T(Treg)细胞稳定分化和抑制功能的标志。以前旨在实现人类初始 T 细胞分化的方案未能实现 Treg 细胞特异性的表观遗传特征。Ten-eleven translocation(TET)酶催化 DNA 去甲基化。构建了包含无功能 Cas9、TET1 的催化结构域、蓝色荧光蛋白以及靶向 FOXP3-TSDR 特定片段的单指导 RNA(sgRNA)的融合蛋白表达质粒,并转染 Jurkat T 细胞。通过深度扩增子亚硫酸氢盐测序分析 FOXP3-TSDR 甲基化,通过实时 PCR 测定细胞 Foxp3、Tbet、Gata3 和 Rorgt mRNA 水平。dCas9TET1 的过表达显著降低了 Jurkat 细胞 FOXP3-TSDR 的甲基化水平,并增加了 Foxp3 mRNA 的表达,而其他主要 T 细胞谱系的主转录因子 mRNA 的表达基本不受影响。dCas9-TET1 构建体转染介导患者原代 T 细胞的 Treg 编程可能是可行的。

相似文献

1
CRISPR/Cas9-mediated demethylation of FOXP3-TSDR toward Treg-characteristic programming of Jurkat T cells.CRISPR/Cas9 介导的 FOXP3-TSDR 去甲基化促进 Jurkat T 细胞向 Treg 特征性编程。
Cell Immunol. 2022 Jan;371:104471. doi: 10.1016/j.cellimm.2021.104471. Epub 2021 Dec 20.
2
Targeted De-Methylation of the FOXP3-TSDR Is Sufficient to Induce Physiological FOXP3 Expression but Not a Functional Treg Phenotype.靶向去甲基化 FOXP3-TSDR 足以诱导生理性 FOXP3 表达,但不能诱导功能性 Treg 表型。
Front Immunol. 2021 Jan 7;11:609891. doi: 10.3389/fimmu.2020.609891. eCollection 2020.
3
Stabilization of Foxp3 expression by CRISPR-dCas9-based epigenome editing in mouse primary T cells.基于CRISPR-dCas9的表观基因组编辑在小鼠原代T细胞中对Foxp3表达的稳定作用。
Epigenetics Chromatin. 2017 May 8;10:24. doi: 10.1186/s13072-017-0129-1. eCollection 2017.
4
Mbd2 promotes foxp3 demethylation and T-regulatory-cell function.Mbd2 促进 foxp3 去甲基化和 T 调节细胞功能。
Mol Cell Biol. 2013 Oct;33(20):4106-15. doi: 10.1128/MCB.00144-13. Epub 2013 Aug 26.
5
Down-regulation of Tet2 is associated with Foxp3 TSDR hypermethylation in regulatory T cell of allergic rhinitis.Tet2 的下调与过敏性鼻炎调节性 T 细胞中 Foxp3 TSDR 的超甲基化有关。
Life Sci. 2020 Jan 15;241:117101. doi: 10.1016/j.lfs.2019.117101. Epub 2019 Nov 25.
6
Impact of 5-aza-2'-deoxycytidine and epigallocatechin-3-gallate for induction of human regulatory T cells.5-氮杂-2'-脱氧胞苷和表没食子儿茶素没食子酸酯诱导人调节性 T 细胞的作用。
Immunology. 2014 Jul;142(3):384-95. doi: 10.1111/imm.12261.
7
Hypomethylation of the Treg-Specific Demethylated Region in FOXP3 Is a Hallmark of the Regulatory T-cell Subtype in Adult T-cell Leukemia.FOXP3 特异性去甲基化区域的低甲基化是成人 T 细胞白血病中调节性 T 细胞亚型的特征。
Cancer Immunol Res. 2016 Feb;4(2):136-45. doi: 10.1158/2326-6066.CIR-15-0148. Epub 2015 Dec 17.
8
Dynamic Imprinting of the Treg Cell-Specific Epigenetic Signature in Developing Thymic Regulatory T Cells.在胸腺调节性 T 细胞发育过程中动态印迹 Treg 细胞特异性表观遗传特征。
Front Immunol. 2019 Oct 11;10:2382. doi: 10.3389/fimmu.2019.02382. eCollection 2019.
9
Analysis of Helios gene expression and Foxp3 TSDR methylation in the newly diagnosed Rheumatoid Arthritis patients.新诊断类风湿关节炎患者中Helios基因表达及Foxp3调节性T细胞脱甲基区域甲基化分析
Immunol Invest. 2018 Aug;47(6):632-642. doi: 10.1080/08820139.2018.1480029. Epub 2018 May 31.
10
Disabled C3ar1/C5ar1 Signaling in Foxp3+ T Regulatory Cells Leads to TSDR Demethylation and Long-Term Stability.Foxp3+T 调节性细胞中 C3ar1/C5ar1 信号的失活导致 TSDR 去甲基化和长期稳定。
J Immunol. 2023 Nov 1;211(9):1359-1366. doi: 10.4049/jimmunol.2300184.

引用本文的文献

1
CRISPR/Cas9 technology in tumor research and drug development application progress and future prospects.CRISPR/Cas9技术在肿瘤研究及药物研发中的应用进展与未来前景
Front Pharmacol. 2025 Jul 8;16:1552741. doi: 10.3389/fphar.2025.1552741. eCollection 2025.
2
Induction of FoxP3 Pre-mRNA Alternative Splicing to Enhance the Suppressive Activity of Regulatory T Cells from Amyotrophic Lateral Sclerosis Patients.诱导FoxP3前体信使核糖核酸可变剪接以增强肌萎缩侧索硬化症患者调节性T细胞的抑制活性
Biomedicines. 2024 May 7;12(5):1022. doi: 10.3390/biomedicines12051022.
3
Targeted Demethylation of FOXP3-TSDR Enhances the Suppressive Capacity of STAT6-deficient Inducible T Regulatory Cells.
靶向性地去除 FOXP3-TSDR 可增强 STAT6 缺陷型诱导性 T 调节细胞的抑制能力。
Inflammation. 2024 Dec;47(6):2159-2172. doi: 10.1007/s10753-024-02031-4. Epub 2024 May 3.
4
Expanded Alternatives of CRISPR-Cas9 Applications in Immunotherapy of Colorectal Cancer.CRISPR-Cas9 应用在结直肠癌免疫治疗中的扩展选择。
Mol Diagn Ther. 2024 Jan;28(1):69-86. doi: 10.1007/s40291-023-00680-z. Epub 2023 Oct 31.
5
Unlocking the potential of Tregs: innovations in CAR technology.释放调节性T细胞的潜力:嵌合抗原受体技术的创新
Front Mol Biosci. 2023 Oct 12;10:1267762. doi: 10.3389/fmolb.2023.1267762. eCollection 2023.
6
Targeted DNA Demethylation: Vectors, Effectors and Perspectives.靶向DNA去甲基化:载体、效应物与展望
Biomedicines. 2023 Apr 30;11(5):1334. doi: 10.3390/biomedicines11051334.
7
Epigenetic Regulation of β-Globin Genes and the Potential to Treat Hemoglobinopathies through Epigenome Editing.通过表观基因组编辑调控β-珠蛋白基因表达治疗血红蛋白病的研究进展
Genes (Basel). 2023 Feb 25;14(3):577. doi: 10.3390/genes14030577.
8
Nature vs. nurture: FOXP3, genetics, and tissue environment shape Treg function.先天与后天:FOXP3、遗传与组织微环境塑造 Treg 功能。
Front Immunol. 2022 Aug 12;13:911151. doi: 10.3389/fimmu.2022.911151. eCollection 2022.